Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology

Sponsor
Boston Children's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04900597
Collaborator
(none)
45
1
3
30
1.5

Study Details

Study Description

Brief Summary

Blenderized diets consist of a wide range of table foods such as fruits, vegetables, meat and legumes, pureed in a blender and administered via gastrostomy tube. In a recent study, the investigators reported that children receiving blenderized feeds via gastrostomy had fewer total admissions and respiratory admissions, total emergency room visits, and improved gastrointestinal symptom scores compared to those fed formula. The goal of this project is to understand how these diets affect gastroesophageal reflux burden.

Condition or Disease Intervention/Treatment Phase
  • Other: Elecare Jr
  • Other: Nourish
  • Other: Real Foods Blends
N/A

Detailed Description

The investigators hypothesize that rates of gastroesophageal reflux will be lower in blenderized diets compared to formula. The investigators will determine if reflux burden as measured by multichannel intraluminal impedance/esophageal pH monitoring performed for clinical purposes differs between low viscosity conventional formula, medium viscosity commercial blenderized diet, and high viscosity commercial blenderized diet in 45 children receiving conventional formula via gastrostomy. All participants will receive each of the three test diets in random order in a 3-way crossover design. Results of gastric emptying scans will be recorded if done for clinical purposes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology
Actual Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Elecare - Nourish - Real Foods Blends

Elecare for first bolus, Nourish for second bolus, Real Foods Blends for third bolus

Other: Elecare Jr
Elecare Jr is a standard pediatric elemental formula

Other: Nourish
Nourish is a commercially prepared blenderized tube feed that is formulated for pediatric use

Other: Real Foods Blends
Real Foods Blends is a commercially prepared blenderized tube feed that is formulated for pediatric use

Experimental: Nourish - Real Foods Blends - Elecare

Nourish for first bolus, Real Foods Blends for second bolus, Elecare for first bolus

Other: Elecare Jr
Elecare Jr is a standard pediatric elemental formula

Other: Nourish
Nourish is a commercially prepared blenderized tube feed that is formulated for pediatric use

Other: Real Foods Blends
Real Foods Blends is a commercially prepared blenderized tube feed that is formulated for pediatric use

Experimental: Real Foods Blends - Elecare - Nourish

Real Foods Blends for first bolus, Elecare for second bolus, Nourish for third bolus

Other: Elecare Jr
Elecare Jr is a standard pediatric elemental formula

Other: Nourish
Nourish is a commercially prepared blenderized tube feed that is formulated for pediatric use

Other: Real Foods Blends
Real Foods Blends is a commercially prepared blenderized tube feed that is formulated for pediatric use

Outcome Measures

Primary Outcome Measures

  1. Reflux episodes [4 hours (following feed)]

    Number of total reflux episodes (acid and non-acid) by impedance

Secondary Outcome Measures

  1. Full column reflux episodes [4 hours (following feed)]

    Total number of full-column reflux episodes by impedance

  2. Percent of time esophageal pH < 4 [4 hours after feed]

    Percent of time esophageal pH < 4 by impedance

  3. Average height of refluxate [4 hours after feed]

    Average height of refluxate by impedance

  4. Number of symptoms [4 hours after feed]

    Frequency of pulmonary and gastrointestinal symptoms from questionnaires during impedance

Other Outcome Measures

  1. Gastric emptying (percent of ingested contents remaining in stomach at 1 hour) [1 hour]

    Gastric emptying scans by scintigraphy will be analyzed if performed for clinical reasons

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 21 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 1-21 years

  • G-tube

  • Able to tolerate bolus gastric feeds over 30 minutes

  • Use of conventional enteral formula

  • Undergoing impedance study for clinical purposes

Exclusion Criteria:
  • History of allergy or intolerance to any component of the test diets

  • History of Nissen fundoplication

  • Current use of non-invasive pressure support (continuous or bi-level positive airway pressure)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Boston Children's Hospital Boston Massachusetts United States 02115

Sponsors and Collaborators

  • Boston Children's Hospital

Investigators

  • Principal Investigator: Bridget M Hron, MD, Boston Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bridget Hron, Staff Physician, Boston Children's Hospital
ClinicalTrials.gov Identifier:
NCT04900597
Other Study ID Numbers:
  • IRB-P00037093
First Posted:
May 25, 2021
Last Update Posted:
Nov 11, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 11, 2021